ArticleGates open research2018
Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.
Article in Gates open research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.PharmacoEconomics · 2024Pooled it
- A Systematic Review of the Cost-Effectiveness of Cleft Care in Low- and Middle-Income Countries: What is Needed?The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2023Pooled it
- Direct, Indirect, and Intangible Costs in the Management of Dental Caries in Children Under 18: A Systematic Review.Dentistry journal · 2026Review
- Points to consider for incorporating climate impacts into health economic evaluation.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Cost-effectiveness analysis of the 13-valent pneumococcal conjugate vaccine administered to children under 5 years of age in the Republic of Moldova.Medicine and pharmacy reports · 2025Article
- A cost-effectiveness analysis of a South African pregnancy support grant.PLOS global public health · 2024Article
- Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis-with an illustrative case of HIV treatment in Mozambique.Cost effectiveness and resource allocation : C/E · 2023Article
- Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment.The Lancet regional health. Southeast Asia · 2023Review
- Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.Applied health economics and health policy · 2022Article
- An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.Addiction (Abingdon, England) · 2022Article
- Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE.International journal of health policy and management · 2021Review
- Bridging the gap: aligning economic research with disease burden.BMJ global health · 2021Article
- An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.Frontiers in public health · 2021Review
- Growth and capacity for cost-effectiveness analysis in Africa.Health economics · 2020Article
- Economic evaluation studies in the field of HIV/AIDS: bibliometric analysis on research development and scopes (GAPBMC health services research · 2019Article
- Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stageCost effectiveness and resource allocation : C/E · 2019Article
- Article
- Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.Gates open research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.